Opioids for Acute Pain Management in Patients With Obstructive Sleep Apnea: A Systematic Review
- PMID: 29958218
- DOI: 10.1213/ANE.0000000000003549
Opioids for Acute Pain Management in Patients With Obstructive Sleep Apnea: A Systematic Review
Abstract
The intrinsic nature of opioids to suppress respiratory function is of particular concern among patients with obstructive sleep apnea (OSA). The association of OSA with increased perioperative risk has raised the question of whether patients with OSA are at higher risk for opioid-induced respiratory depression (OIRD) compared to the general population. The aims of this systematic review were to summarize current evidence with respect to perioperative OIRD, changes in sleep-disordered breathing, and alterations in pain and opioid sensitivity in patients with OSA. A systematic literature search of studies published between 1946 and October 2017 was performed utilizing the following databases: Medline, ePub Ahead of Print/Medline In-process, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, PubMed-NOT-Medline and ClinicalTrials.Gov. Of 4321 initial studies, 40 met the inclusion criteria. The Oxford level of evidence was assessed. Overall, high-quality evidence on the comparative impact of acute opioid analgesia in OSA versus non-OSA patients is lacking. The current body of evidence is burdened by significant limitations including risk of bias and large heterogeneity among studies with regard to OSA severity, perioperative settings, outcome definitions, and the presence or absence of various perioperative drivers. These factors complicate an accurate interpretation and robust analysis of the true complication risk. Nevertheless, there is some consistency among studies with regard to a detrimental effect of opioids in the presence of OSA. Notably, the initial 24 hours after opioid administration appear to be most critical with regard to life-threatening OIRD. Further, OSA-related increased pain perception and enhanced opioid sensitivity could predispose patients with OSA to a higher risk for OIRD without overdosing. While high-quality evidence is needed, retrospective analyses indicate that critical, life-threatening OIRD may be preventable with a more cautious approach to opioid use, including adequate monitoring.
Similar articles
-
Risk factors for opioid-induced respiratory depression in surgical patients: a systematic review and meta-analyses.BMJ Open. 2018 Dec 14;8(12):e024086. doi: 10.1136/bmjopen-2018-024086. BMJ Open. 2018. PMID: 30552274 Free PMC article.
-
Preventing Opioid-Induced Respiratory Depression in the Hospitalized Patient With Obstructive Sleep Apnea.J Perianesth Nurs. 2018 Oct;33(5):601-607. doi: 10.1016/j.jopan.2016.09.013. Epub 2017 Sep 15. J Perianesth Nurs. 2018. PMID: 30236566 Review.
-
Perioperative Management of the Patient With Obstructive Sleep Apnea: A Narrative Review.Anesth Analg. 2021 May 1;132(5):1231-1243. doi: 10.1213/ANE.0000000000005444. Anesth Analg. 2021. PMID: 33857965 Review.
-
Pharmacovigilance: a review of opioid-induced respiratory depression in chronic pain patients.Pain Physician. 2013 Mar-Apr;16(2):E85-94. Pain Physician. 2013. PMID: 23511694 Review.
-
Risk predictors of opioid-induced critical respiratory events in children: naloxone use as a quality measure of opioid safety.Pain Med. 2014 Dec;15(12):2139-49. doi: 10.1111/pme.12575. Epub 2014 Oct 15. Pain Med. 2014. PMID: 25319840
Cited by
-
Sufentanil combined with nalmefene reduce the adverse events in recovery period of patients undergoing uvulopalatopharyngoplasty - A randomized controlled trial.Heliyon. 2023 Jan 26;9(2):e13241. doi: 10.1016/j.heliyon.2023.e13241. eCollection 2023 Feb. Heliyon. 2023. PMID: 36755590 Free PMC article.
-
Opioid dose and postoperative respiratory adverse events after adenotonsillectomy in medically complex children.J Clin Sleep Med. 2022 Oct 1;18(10):2405-2413. doi: 10.5664/jcsm.10120. J Clin Sleep Med. 2022. PMID: 35801349 Free PMC article.
-
Low Incidence of Opioid-Induced Respiratory Depression Observed with Oliceridine Regardless of Age or Body Mass Index: Exploratory Analysis from a Phase 3 Open-Label Trial in Postsurgical Pain.Pain Ther. 2021 Jun;10(1):457-473. doi: 10.1007/s40122-020-00232-x. Epub 2021 Jan 21. Pain Ther. 2021. PMID: 33502739 Free PMC article.
-
Neostigmine Versus Sugammadex for Reversal of Neuromuscular Blockade and Effects on Reintubation for Respiratory Failure or Newly Initiated Noninvasive Ventilation: An Interrupted Time Series Design.Anesth Analg. 2020 Jul;131(1):141-151. doi: 10.1213/ANE.0000000000004505. Anesth Analg. 2020. PMID: 31702700 Free PMC article. Clinical Trial.
-
Perioperative Pain Management in Bariatric Anesthesia.Saudi J Anaesth. 2022 Jul-Sep;16(3):339-346. doi: 10.4103/sja.sja_236_22. Epub 2022 Jun 20. Saudi J Anaesth. 2022. PMID: 35898528 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous